Literature DB >> 24657130

The 'immunologic theory' of preeclampsia revisited: a lesson from donor oocyte gestations.

Yacov Levron1, Michal Dviri1, Inbar Segol1, Gil M Yerushalmi1, Ariel Hourvitz1, Raoul Orvieto1, Shali Mazaki-Tovi1, Yoav Yinon1.   

Abstract

OBJECTIVE: To determine the prevalence of placental complications in patients conceived through donor versus autologous oocytes. STUDY
DESIGN: A retrospective cohort study including 2 groups of patients who conceived through in vitro fertilization using: (1) donor oocyte (n = 139) and (2) autologous oocyte (n = 126). Only singleton gestations were included. The rate of placental complications including preeclampsia, gestational hypertension, and intrauterine growth restriction was compared between these 2 groups.
RESULTS: The women who conceived using donor oocytes were older compared with women who conceived using autologous oocytes (median maternal age 45 vs 41, P < .01). The rate of hypertensive diseases of pregnancy including gestational hypertension and preeclampsia was significantly higher in ovum donor recipients compared with women conceived with autologous oocytes (25% vs 10%, P < .01). Similarly, the rate of intrauterine growth restriction was also higher among patients conceived through oocyte donation although it did not reach statistical significance (9.3% vs 4%, P = .08). When maternal age was restricted to ≤45 years, the rate of hypertensive diseases of pregnancy remained significantly higher among ovum donor compared with autologous oocyte recipients (22% vs 10%, P = .02). Adjustment for maternal age, gravidity, parity, and chronic hypertension revealed that oocyte donation was independently associated with higher rate of hypertensive diseases of pregnancy (P = .01).
CONCLUSION: Patients conceived through oocyte donation have an increased risk for placental complications of pregnancy. These findings support the 'immunologic theory' suggesting that immunologic intolerance between the mother and the fetus may play an important role in the pathogenesis of preeclampsia.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  donor oocyte; obstetric outcome; preeclampsia; pregnancy induced hypertension

Mesh:

Year:  2014        PMID: 24657130     DOI: 10.1016/j.ajog.2014.03.044

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  29 in total

1.  The impact of using donor sperm in assisted reproductive technology cycles on perinatal outcomes.

Authors:  Bo Yu; Rani Fritz; Xianhong Xie; Abdissa Negassa; Sangita Jindal; Mario Vega; Erkan Buyuk
Journal:  Fertil Steril       Date:  2018-12       Impact factor: 7.329

2.  Maternal and neonatal outcomes associated with trophectoderm biopsy.

Authors:  Wendy Y Zhang; Frauke von Versen-Höynck; Kristopher I Kapphahn; Raquel R Fleischmann; Qianying Zhao; Valerie L Baker
Journal:  Fertil Steril       Date:  2019-05-15       Impact factor: 7.329

Review 3.  Preeclampsia: What Does the Father Have to Do with It?

Authors:  V Katsi; I Felekos; C Siristatidis; S Kasioni; A Drakontaidis; G Farmakides; T Makris; C Aggeli; P Nihoyannopoulos; D Tousoulis; I Kallikazaros
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

4.  Assisted reproduction and risk of preterm birth in singletons by infertility diagnoses and treatment modalities: a population-based study.

Authors:  Galit Levi Dunietz; Claudia Holzman; Yujia Zhang; Chenxi Li; David Todem; Sheree L Boulet; Patricia McKane; Dmitry M Kissin; Glenn Copeland; Dana Bernson; Michael P Diamond
Journal:  J Assist Reprod Genet       Date:  2017-07-28       Impact factor: 3.412

Review 5.  A new era in reproductive medicine: consequences of third-party oocyte donation for maternal and fetal health.

Authors:  Shigeru Saito; Yasushi Nakabayashi; Akitoshi Nakashima; Tomoko Shima; Osamu Yoshino
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

6.  Association between in vitro fertilization and ischemic placental disease by gestational age.

Authors:  Katherine M Johnson; Michele R Hacker; Kim Thornton; Brett C Young; Anna M Modest
Journal:  Fertil Steril       Date:  2020-07-22       Impact factor: 7.329

7.  Pregnancy outcomes in very advanced maternal age pregnancies: the impact of assisted reproductive technology.

Authors:  Sherri Jackson; Connie Hong; Erica T Wang; Carolyn Alexander; Kimberly D Gregory; Margareta D Pisarska
Journal:  Fertil Steril       Date:  2014-10-25       Impact factor: 7.329

8.  Risk of ischemic placental disease in fresh and frozen embryo transfer cycles.

Authors:  Katherine M Johnson; Michele R Hacker; Nina Resetkova; Barbara O'Brien; Anna M Modest
Journal:  Fertil Steril       Date:  2019-02-28       Impact factor: 7.329

9.  Is the risk of preeclampsia higher in donor oocyte pregnancies? A systematic review and meta-analysis.

Authors:  Juan Enrique Schwarze; Paula Borda; Pamela Vásquez; Carolina Ortega; Sonia Villa; Javier A Crosby; Ricardo Pommer
Journal:  JBRA Assist Reprod       Date:  2018-03-01

10.  Effect of oocyte donor stimulation on recipient outcomes: data from a US national donor oocyte bank.

Authors:  H S Hipp; A J Gaskins; Z P Nagy; S M Capelouto; D B Shapiro; J B Spencer
Journal:  Hum Reprod       Date:  2020-04-28       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.